Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2018

23.03.2018

Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients

verfasst von: Usama A. Daimee, Helmut U. Klein, Michael C. Giudici, Wojciech Zareba, Scott McNitt, Bronislava Polonsky, Arthur J. Moss, Valentina Kutyifa

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The effects of right ventricular (RV) lead location and the combination of RV and left ventricular (LV) lead locations on long-term outcomes in patients receiving cardiac resynchronization therapy with defibrillator (CRT-D) are not well understood.

Methods

Our cohort consisted of 743 CRT-D patients from MADIT-CRT. We evaluated long-term death and combined heart failure or death (HF/death) in patients with non-apical RV vs. apical RV leads. We further assessed these long-term outcomes based on the combination of RV and LV leads, termed “RV-LV lead interaction.” Patients with non-apical RV and apical LV leads and those with apical RV and non-apical LV leads were described to have “discordant RV and LV leads.” Patients with RV and LV leads that were both non-apical or both apical were defined to have “concordant RV and LV leads.”

Results

There were no differences in death and HF/death between patients with non-apical RV vs. apical RV leads. However, patients with non-apical RV and apical LV leads had higher mortality risk, relative to those with apical RV and non-apical LV leads (HR = 4.06, 95% CI 1.73–9.53, p = 0.001) as well as those with both leads in the non-apical (HR = 3.82, 95% CI 1.33–10.98, p = 0.013) or apical (HR = 3.40, 95% CI 1.24–9.37, p = 0.018) positions. There was no difference in HF/death by RV-LV lead sub-groups.

Conclusion

Among CRT-D patients, long-term outcomes were similar for non-apical RV and apical RV leads. However, mortality risk was increased with discordant RV and LV leads, when a non-apical RV lead was combined with an apical LV lead.
Literatur
1.
Zurück zum Zitat Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.CrossRefPubMed Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.CrossRefPubMed
2.
Zurück zum Zitat Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.CrossRefPubMed Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.CrossRefPubMed
3.
Zurück zum Zitat Linde C, Abraham WT, Gold MR, Sutton MSJ, Ghio S, Daubert C, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834–43.CrossRefPubMed Linde C, Abraham WT, Gold MR, Sutton MSJ, Ghio S, Daubert C, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834–43.CrossRefPubMed
4.
Zurück zum Zitat Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, et al. Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10:34–43.CrossRefPubMed Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, et al. Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10:34–43.CrossRefPubMed
5.
Zurück zum Zitat Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–38.CrossRefPubMed Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–38.CrossRefPubMed
6.
Zurück zum Zitat Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385–95.CrossRefPubMed Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385–95.CrossRefPubMed
7.
Zurück zum Zitat Goldenberg I, Kutyifa V, Klein HU, Cannom DS, Brown MW, Dan A, et al. Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med. 2014;370:1694–701.CrossRefPubMed Goldenberg I, Kutyifa V, Klein HU, Cannom DS, Brown MW, Dan A, et al. Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med. 2014;370:1694–701.CrossRefPubMed
8.
Zurück zum Zitat Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27:1928–32.CrossRefPubMed Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27:1928–32.CrossRefPubMed
9.
Zurück zum Zitat Riedlbauchová L, Cihák R, Bytesník J, Vancura V, Frídl P, Hosková L, et al. Optimization of right ventricular lead position in cardiac resynchronisation therapy. Eur J Heart Fail. 2006;8:609–14.CrossRefPubMed Riedlbauchová L, Cihák R, Bytesník J, Vancura V, Frídl P, Hosková L, et al. Optimization of right ventricular lead position in cardiac resynchronisation therapy. Eur J Heart Fail. 2006;8:609–14.CrossRefPubMed
10.
Zurück zum Zitat Miranda R, Nault M, Johri A, Simpson C, Michael K, Abdollah H, et al. Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy. Circ Arrhythm Electrophysiol. 2012;5:927–32.CrossRefPubMed Miranda R, Nault M, Johri A, Simpson C, Michael K, Abdollah H, et al. Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy. Circ Arrhythm Electrophysiol. 2012;5:927–32.CrossRefPubMed
11.
Zurück zum Zitat Miranda RI, Nault M, Simpson CS, Michael KA, Abdollah H, Baranchuk A, et al. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing. J Cardiovasc Electrophysiol. 2012;23:370–4.CrossRefPubMed Miranda RI, Nault M, Simpson CS, Michael KA, Abdollah H, Baranchuk A, et al. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing. J Cardiovasc Electrophysiol. 2012;23:370–4.CrossRefPubMed
12.
Zurück zum Zitat Khan FZ, Salahshouri P, Duehmke R, Read PA, Pugh PJ, Elsik M, et al. The impact of the right ventricular lead position on response to cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2011;34:467–74.CrossRefPubMed Khan FZ, Salahshouri P, Duehmke R, Read PA, Pugh PJ, Elsik M, et al. The impact of the right ventricular lead position on response to cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2011;34:467–74.CrossRefPubMed
13.
Zurück zum Zitat Kristiansen H, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy. Eur J Heart Fail. 2012;14:506–16.CrossRefPubMed Kristiansen H, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy. Eur J Heart Fail. 2012;14:506–16.CrossRefPubMed
14.
Zurück zum Zitat Thébault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR, et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J. 2012;33:2662–71.CrossRefPubMed Thébault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR, et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J. 2012;33:2662–71.CrossRefPubMed
15.
Zurück zum Zitat Kutyifa V, Thomsen PEB, Huang DT, Rosero S, Tompkins C, Jons C, et al. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Heart Rhythm. 2013;10:1770–7.CrossRefPubMed Kutyifa V, Thomsen PEB, Huang DT, Rosero S, Tompkins C, Jons C, et al. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Heart Rhythm. 2013;10:1770–7.CrossRefPubMed
16.
Zurück zum Zitat Asbach S, Lennerz C, Semmler V, Grebmer C, Solzbach U, Kloppe A, et al. Impact of the right ventricular lead position on clinical end points in CRT recipients—a subanalysis of the multicenter randomized SPICE trial. Pacing Clin Electrophysiol. 2016;39:261–7.CrossRefPubMed Asbach S, Lennerz C, Semmler V, Grebmer C, Solzbach U, Kloppe A, et al. Impact of the right ventricular lead position on clinical end points in CRT recipients—a subanalysis of the multicenter randomized SPICE trial. Pacing Clin Electrophysiol. 2016;39:261–7.CrossRefPubMed
17.
Zurück zum Zitat Leclercq C, Sadoul N, Mont L, Defaye P, Osca J, Mouton E, et al. Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study. Eur Heart J. 2016;37:473–83.CrossRefPubMed Leclercq C, Sadoul N, Mont L, Defaye P, Osca J, Mouton E, et al. Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study. Eur Heart J. 2016;37:473–83.CrossRefPubMed
18.
Zurück zum Zitat Zografos TA, Siontis KC, Jastrzebski M, Kutyifa V, Klein HU, Zareba W, et al. Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis. Europace. 2015;17:1259–66.CrossRefPubMed Zografos TA, Siontis KC, Jastrzebski M, Kutyifa V, Klein HU, Zareba W, et al. Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis. Europace. 2015;17:1259–66.CrossRefPubMed
19.
Zurück zum Zitat Merchant F, Heist E, McCarty D, Kumar P, Das S, Blendea D, et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm. 2010;7:639.CrossRefPubMed Merchant F, Heist E, McCarty D, Kumar P, Das S, Blendea D, et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm. 2010;7:639.CrossRefPubMed
20.
Zurück zum Zitat Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) TrialClinical perspective. Circulation. 2011;123:1159–66.CrossRefPubMed Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) TrialClinical perspective. Circulation. 2011;123:1159–66.CrossRefPubMed
21.
Zurück zum Zitat Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, Goldenberg I, Huang DT, Merkely B and Wang PJ. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2012;ehs334. Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, Goldenberg I, Huang DT, Merkely B and Wang PJ. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2012;ehs334.
22.
Zurück zum Zitat Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.CrossRefPubMed Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.CrossRefPubMed
23.
Zurück zum Zitat Knappe D, Pouleur A-C, Shah AM, Cheng S, Uno H, Hall WJ, et al. Dyssynchrony, contractile function, and response to cardiac resynchronization TherapyClinical perspective. Circ Heart Fail. 2011;4:433–40.CrossRefPubMed Knappe D, Pouleur A-C, Shah AM, Cheng S, Uno H, Hall WJ, et al. Dyssynchrony, contractile function, and response to cardiac resynchronization TherapyClinical perspective. Circ Heart Fail. 2011;4:433–40.CrossRefPubMed
24.
Zurück zum Zitat Pouleur A-C, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, et al. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011;32:1720–9.CrossRefPubMed Pouleur A-C, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, et al. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011;32:1720–9.CrossRefPubMed
25.
Zurück zum Zitat Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, et al. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure. Europace. 2009;11:356–63.CrossRefPubMed Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, et al. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure. Europace. 2009;11:356–63.CrossRefPubMed
26.
Zurück zum Zitat Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith RE, Jordan PJ, et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol. 2007;50:243–52.CrossRefPubMed Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith RE, Jordan PJ, et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol. 2007;50:243–52.CrossRefPubMed
27.
Zurück zum Zitat Kutyifa V, Pouleur A-C, Knappe D, Al-Ahmad A, Gibinski M, Wang PJ, et al. Dyssynchrony and the risk of ventricular arrhythmias. J Am Coll Cardiol Img. 2013;6:432–44.CrossRef Kutyifa V, Pouleur A-C, Knappe D, Al-Ahmad A, Gibinski M, Wang PJ, et al. Dyssynchrony and the risk of ventricular arrhythmias. J Am Coll Cardiol Img. 2013;6:432–44.CrossRef
Metadaten
Titel
Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients
verfasst von
Usama A. Daimee
Helmut U. Klein
Michael C. Giudici
Wojciech Zareba
Scott McNitt
Bronislava Polonsky
Arthur J. Moss
Valentina Kutyifa
Publikationsdatum
23.03.2018
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2018
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0332-4

Weitere Artikel der Ausgabe 2/2018

Journal of Interventional Cardiac Electrophysiology 2/2018 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.